Efficacy and Tolerability of 75 mg Risedronate Dosed on Two Consecutive Days a Month for the Treatment of Postmenopausal Osteoporosis Over 2 Years

Journal article

Michael McClung, Ana Balske, Ellen Matzkin, W. P. Olszynski and Robert R. Recker

Osteoporosis International, Vol.20, p.S210

04/2009

Metrics

4 Record Views

Title: Efficacy and Tolerability of 75 mg Risedronate Dosed on Two Consecutive Days a Month for the Treatment of Postmenopausal Osteoporosis Over 2 Years
Creators: Michael McClung (Author)
Ana Balske (Author)
Ellen Matzkin (Author)
W. P. Olszynski (Author)
Robert R. Recker (Author) - Creighton University
Publication Details: Osteoporosis International, Vol.20, p.S210
Number of pages: S210
Identifiers: 991005932085902656
Academic Unit: School of Medicine; Endocrine
Resource Type: Journal article